Terms: = Head and neck cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
2229 results:
1. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract] [Full Text] [Related]
2. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
3. Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
Chen Y; Huang Y; Chen X; Chen Z; Peng X; Lin S; Lin C; Zong J
BMC Cancer; 2024 Apr; 24(1):483. PubMed ID: 38627711
[TBL] [Abstract] [Full Text] [Related]
4. Impact Of PET/CT On Treatment In Patients With head and neck Squamous Cell Carcinoma.
García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; Andrés-Gracia A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
Otolaryngol Pol; 2024 Apr; 78(2):29-34. PubMed ID: 38623858
[TBL] [Abstract] [Full Text] [Related]
5. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
6. Utilizing the AJCC 8
Kim SI; Lee JW; Eun YG; Lee YC
Anticancer Res; 2024 Apr; 44(4):1703-1710. PubMed ID: 38538003
[TBL] [Abstract] [Full Text] [Related]
7. How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.
Ferrari M; Mularoni F; Taboni S; Crosetti E; Pessina C; Carobbio ALC; Montalto N; Marchi F; Vural A; Paderno A; Caprioli S; Gaudioso P; Fermi M; Rigoni F; Saccardo T; Contro G; Ruaro A; Lo Manto A; Varago C; Baldovin M; Bandolin L; Filauro M; Sampieri C; Missale F; Ioppi A; Carta F; Ramanzin M; Ravanelli M; Maiolo V; Bertotto I; Del Bon F; Lancini D; Mariani C; Marrosu V; Tatti M; Cağlı S; Yüce I; Gündoğ M; Dogan S; Anile G; Gottardi C; Busato F; Vallin A; Gennarini F; Bossi P; Ghi MG; Lionello M; Zanoletti E; Marioni G; Maroldi R; Mattioli F; Puxeddu R; Bertolin A; Presutti L; Piazza C; Succo G; Peretti G; Nicolai P
Oral Oncol; 2024 May; 152():106744. PubMed ID: 38520756
[TBL] [Abstract] [Full Text] [Related]
8. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of nomogram models for predicting postoperative prognosis of early-stage laryngeal squamous cell carcinoma.
Juan X; Jiali H; Ziqi L; Liqing Z; Han Z
Curr Probl Cancer; 2024 Apr; 49():101079. PubMed ID: 38492281
[TBL] [Abstract] [Full Text] [Related]
10. 3D-IncNet: head and neck (H&N) Primary Tumors Segmentation and Survival Prediction.
Qayyum A; Benzinou A; Razzak I; Mazher M; Nguyen TT; Puig D; Vafaee F
IEEE J Biomed Health Inform; 2024 Mar; 28(3):1185-1194. PubMed ID: 38446658
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
[TBL] [Abstract] [Full Text] [Related]
12. A deep learning method for multi-task intelligent detection of oral cancer based on optical fiber Raman spectroscopy.
Li L; Yu M; Li X; Ma X; Zhu L; Zhang T
Anal Methods; 2024 Mar; 16(11):1659-1673. PubMed ID: 38419435
[TBL] [Abstract] [Full Text] [Related]
13. Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.
Chen Z; Liang Z; Chen K; Zhang S; Huang X; Wu G; Zhu X
Sci Rep; 2024 Feb; 14(1):4311. PubMed ID: 38383702
[TBL] [Abstract] [Full Text] [Related]
14. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract] [Full Text] [Related]
15. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
16. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
17. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract] [Full Text] [Related]
18. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
19. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
Xie L; Zhang Z
Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
[TBL] [Abstract] [Full Text] [Related]
20. Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study.
Wang T; Wang J; Tang T; Wang L; Li Y; Song X
Neoplasma; 2023 Dec; 70(6):804-810. PubMed ID: 38247337
[TBL] [Abstract] [Full Text] [Related]
[Next]
